Clinical Trial Update: Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation [Phase 4]

View source ↗

Summary

Phase 4 trial assessing sodium bicarbonate 8.4% solution as a catheter lock to prevent lumen clotting and catheter loss in hemodialysis patients; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Renal Failure

Drugs mentioned

• Sodium bicarbonate 8.4% solution (catheter lock) (sodium bicarbonate 8.4% solution)

Snippet

Sponsor: Coney Island Hospital, Brooklyn, NY | Conditions: End Stage Renal Disease, Acute Renal Failure | Phase 4 | Status: COMPLETED